Will Industry's General Pledges On AMR And Calls For Government Cash Cut It At Davos?
This article was originally published in Scrip
For the first time, the drugs and diagnostics industries have banded together to produce a joint declaration on tackling antimicrobial resistance, which they are heralding as a great step forward in tackling the problem and launching during the World Economic Forum in Davos, Switzerland. The pledges are, however, vague and include no specific financial commitments. The declaration calls on governments to front up the cash.
You may also be interested in...
GlamorousAI is developing technology to uncover new targets and take on previously intractable disease challenges. Founder Noor Shaker hopes to license a drug to big pharma within the next three years.
INFOGRAPHIC: In 2019, 10 blockbuster medicines booked combined sales of $92.5bn. This infographic examines those drugs that commanded the greatest revenues globally, and answers some key questions. Which therapeutic areas include the most lucrative blockbusters? Which companies enjoyed their spoils? And which drugs were new to the top 10 last year? It also takes a look at the position of these products on the all-important US market.
Fundraising in the life sciences sector has been booming even as firms in many other industries are struggling to stay in business. Goodwin’s David Mardle is upbeat about the sector’s ongoing prospects – although M&A deals are currently proving tricky to complete.